Paying a Tobacco Surcharge for Health Insurance?

Some employers impose a tobacco surcharge that makes workers pay more for health insurance, because they smoke, vape, use chewing tobacco, snuff or other nicotine products.

You or a family member may have legal claims and may be able to recover some or all of what was paid.

What is a tobacco surcharge?

Many employers charge workers more for workplace health insurance if they or a covered family member use tobacco or nicotine products.

The charge may appear as:

  • A tobacco or nicotine surcharge
  • A higher health insurance premium
  • A wellness charge
  • A tobacco-user rate
  • The loss of a non-tobacco discount

These charges can add up quickly. Even a $20 weekly surcharge can exceed $1,000 in one year.

When might a tobacco surcharge be improper?

Federal employee-benefit law places conditions on certain health-plan wellness programs.

A tobacco or nicotine surcharge may warrant legal review if:

  • No real alternative was offered. You had no meaningful way to qualify for the lower premium, such as participating in a tobacco-cessation program.
  • The alternative was not clearly disclosed. Enrollment materials or premium chart showed the surcharge, but did not clearly explain how to avoid it.
  • You had to actually quit. Participating in or completing a reasonable alternative may be enough even if you continue using tobacco or nicotine.
  • You did not receive the full promised benefit. You completed the program, but the surcharge continued or the plan did not provide the reward described in its terms.

Whether a surcharge is improper depends on the health plan’s documents, disclosures and administration.

Who may be affected by a tobacco surcharge?

Employer definitions vary. A “tobacco surcharge” may apply to:

  • Cigarettes or cigars
  • Pipes or hookah
  • Chewing tobacco or snuff
  • E-cigarettes or vaping devices
  • Synthetic nicotine
  • Other tobacco or nicotine products

Some employers also impose the charge when a spouse, partner or other family member covered by the employee’s health plan uses one of these products.

Could you recover what you paid?

Possibly. Employees have filed class actions alleging that employers collected tobacco or nicotine surcharges without offering a lawful alternative, providing adequate notice or delivering the promised reward.

Courts have reached different results depending on the plan and the employee’s circumstances. Paying a surcharge does not automatically establish a claim, but the charge may warrant investigation.

You or a family member may have legal claims

If you paid a tobacco or nicotine surcharge—or paid more because a family member covered by your workplace health plan used a covered product—you may have legal claims and may be able to recover some or all of the surcharge payments.

Contact Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is investigating employer tobacco and nicotine-related health insurance surcharges.

If you, a friend or a covered family member paid one of these charges, contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], for a free, no-obligation legal evaluation.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally-recognized, plaintiff-side class action law firm representing investors and consumers in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, and retirement-plan mismanagement. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

All representation is provided on a contingency-fee basis, and plaintiffs are not responsible for attorneys’ fees, court costs, or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval. 

 

 

 

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

First BanCorp Fiduciary Duty Investigation – FBP

Kehoe Law Firm, P.C. is investigating whether certain officers and directors of First BanCorp. (“First BanCorp” or the “Company”) (NYSE: FBP) may have breached their fiduciary duties or otherwise failed to oversee and manage the Company appropriately. The investigation also concerns whether First BanCorp and its shareholders may have been harmed as a result.

If you currently own First BanCorp common stock, you may have rights in connection with this investigation.

What Is the Investigation About?

The investigation concerns allegations regarding banking services allegedly provided to Jeffrey Epstein, as well as First BanCorp’s oversight, compliance, and corporate governance.

On June 24, 2026, a plaintiff identified as Jane Doe filed a putative class action lawsuit against First BanCorp, alleging that the bank participated in and financially benefited from Jeffrey Epstein’s sex-trafficking operation.

Kehoe Law Firm is evaluating whether the Company’s officers and directors breached their fiduciary duties in connection with these matters and whether corporate-governance reforms or other relief may be appropriate for First BanCorp.

First BanCorp Shareholders May Have Legal Claims

Current First BanCorp shareholders who wish to learn more about the investigation and their potential legal rights are encouraged to contact the firm by completing Kehoe Law Firm’s Stockholder Information Request Form or contacting:

Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]

There is no cost or obligation to speak with the firm. Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, and clients are not responsible for any fees or litigation expenses.

 

 

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

The Ensign Group Fiduciary Duty Investigation – ENSG

Kehoe Law Firm, P.C. is investigating whether certain officers and directors of The Ensign Group, Inc. (“Ensign,” “Ensign Group,” or the “Company”) (NASDAQ: ENSG) may have breached their fiduciary duties or otherwise failed to oversee and manage the Company appropriately. The investigation also concerns whether Ensign Group and its shareholders may have been harmed as a result.

If you currently own Ensign common stock, you may have rights in connection with this investigation.

What Is the Investigation About?

The investigation concerns allegations regarding Ensign Group’s oversight of its skilled nursing facilities, regulatory compliance, and Medicare and Medicaid billing.

On June 11, 2026, short seller Muddy Waters Research published a report concerning Ensign Group. The report stated that Muddy Waters “. . . conclude[d] that Ensign engages in a systematic scheme at an estimated ~20% of Skilled Nursing Facilities (SNFs) to rent the licenses of Administrators who are not generally present at, nor actually managing, the facilities.”

Muddy Waters stated that it “. . . believe[d] this scheme, which could amount to fraud against states, Medicare, and Medicaid, is the pillar upon which Ensign’s acquisition strategy and margins is built.”

Additionally, the report stated that “[u]nder the False Claims Act, if these practices have been in place for one year at ~20% of facilities, [Muddy Waters] estimate[d] the violations carry theoretical sanctions in the billions of dollars.”

Kehoe Law Firm is evaluating whether the Company’s officers and directors breached their fiduciary duties in connection with these matters and whether corporate governance reforms or other relief may be appropriate for Ensign Group.

Ensign Group Shareholders May Have Legal Claims

Current Ensign Group shareholders who wish to learn more about the investigation and their potential legal rights are encouraged to contact the firm by completing Kehoe Law Firm’s Stockholder Information Request Form or contacting:

Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]

There is no cost or obligation to speak with the firm. Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, and clients are not responsible for any fees or litigation expenses.

 

 

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

ADMA Biologics Fiduciary Duty Investigation – ADMA

Kehoe Law Firm, P.C. is investigating whether certain officers and directors of ADMA Biologics, Inc. (“ADMA,” “ADMA Biologics,” or the “Company”) (NASDAQ: ADMA) may have breached their fiduciary duties or otherwise failed to oversee and manage the Company appropriately. The investigation also concerns whether ADMA Biologics and its shareholders may have been harmed as a result.

If you currently own ADMA Biologics common stock, you may have rights in connection with this investigation.

What Is the Investigation About?

The investigation concerns allegations regarding ADMA Biologics’ reported growth, distribution practices, related-party disclosures, and corporate oversight.

In March 2026, short seller Culper Research published a report alleging, among other things, channel stuffing and an undisclosed related-party distributor. 

On May 6, 2026, ADMA Biologics reported that increased competition, aggressive pricing tactics, and higher inventory across the distribution network affected its first-quarter results, particularly BIVIGAM. 

Kehoe Law Firm is evaluating whether the Company’s officers and directors breached their fiduciary duties in connection with these matters and whether corporate-governance reforms or other relief may be appropriate for ADMA Biologics.

ADMA Biologics Shareholders May Have Legal Claims

Current ADMA Biologics shareholders who wish to learn more about the investigation and their potential legal rights are encouraged to contact the firm by completing Kehoe Law Firm’s Stockholder Information Request Form or contacting:

Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]

There is no cost or obligation to speak with the firm. Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, and clients are not responsible for any fees or litigation expenses.

 

 

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Alibaba Securities Class Action – BABA

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Alibaba Group Holding Limited (“Alibaba” or the “Company”) (NYSE: BABA).

A securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Alibaba securities between June 26, 2025 and June 24, 2026, both dates inclusive (the “Class Period”). 

What Does the Alibaba Securities Class Action Allege?

According to the complaint, Alibaba and its CEO, Eddie Yongming Wu, made materially false and/or misleading statements or failed to disclose adverse facts concerning to the Company’s business which were allegedly known to the Alibaba Defendants or recklessly disregarded by them.

Specifically, the Alibaba Defendants allegedly made false and/or misleading statements and/or failed to disclose that:

1) Under the National Defense Authorization Act (“NDAA”), any entities directly or indirectly controlled by or affiliated with the Chinese Ministry of Industry and Information Technology (“MIIT”) were considered a Chinese military company;

2) Alibaba was directly or indirectly controlled by or affiliated with the MIIT;

3) The risk of Alibaba carrying out distillation attacks against third- party AI models was not a mere hypothetical or inadvertent, but ongoing; and

4) As a result, the Alibaba Defendants’ public statements about Alibaba’s business, operations, and prospects were materially false and/or misleading at all relevant times.

The complaint states that on June 8, 2026, the U.S. Department of Defense released an updated list of Chinese military companies that included Alibaba. According to the complaint, Alibaba’s share price declined $4.69, or approximately 3.9%, over the next two trading days.

The complaint also cites a June 24, 2026 Bloomberg report concerning Anthropic’s accusation that Alibaba had illicitly accessed its Claude artificial intelligence models. According to the complaint, Alibaba ADSs declined 2.7% on June 24 and another 4.7% on June 25, 2026.

Alibaba Investors May Have Legal Claims

Investors who acquired Alibaba securities during the Class Period and suffered an investment loss may have legal claims.

Affected Alibaba investors are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], to discuss the class action, the lead plaintiff process or their potential legal rights.  

Investors have until October 5, 2026 to seek appointment as lead plaintiff. Investors are not required to seek appointment as lead plaintiff to remain potential members of the class. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. An investors ability to share in any potential future recovery is not dependent upon serving as a lead plaintiff. 

There is no cost or obligation to speak with the firm.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Wise Group Class Action Lawsuit on Behalf of Investors – WSE

Investors Who Acquired Wise Group Securities Encouraged to Contact Kehoe Law Firm

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Wise Group plc (“Wise,” “Wise Group,” or the “Company”) (NASDAQ: WSE).

A securities class action lawsuit has been filed against Wise and certain of its executives on behalf of investors who purchased or otherwise acquired publicly traded Wise securities between May 11, 2026 and July 23, 2026, both dates inclusive (the “Class Period”).

The action, captioned Daugherty v. Wise Group plc, et al., Case No. 1:26-cv-06582, was filed on July 31, 2026, in the United States District Court for the Southern District of New York.

Allegations Against Wise Group

The class action complaint alleges that the Wise Group defendants made materially false and/or misleading statements and failed to disclose material adverse facts concerning Wise’s business, operations, and prospects. Specifically, the complaint alleges that the defendants failed to disclose that Wise’s regulatory risks were materially understated as a result of allegedly deficient anti-money laundering efforts and insufficient efforts to prevent the financing of terrorism.

The complaint further alleges that, as a result, the defendants’ statements concerning Wise Group’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis.

Belgian Money-Laundering Investigation

According to the complaint, Reuters reported on June 1, 2026, that the Brussels Public Prosecutor’s Office was investigating Wise’s European entity in connection with matters reportedly involving more than half a billion euros, or approximately $582.5 million, in suspicious transactions.

The complaint states that Reuters reported that the investigation concerned potential money-laundering offenses with alleged connections to fraud, corruption, and drug trafficking. Prosecutors were also reportedly investigating whether international criminal organizations had used Wise Europe’s services.

According to the complaint, following this news, Wise’s U.S.-listed shares declined $0.67 per share, or 5.24%, to close at $12.10 per share on June 1, 2026. The shares subsequently declined $0.56 per share, or 4.6%, to close at $11.54 per share on June 2, 2026, and declined an additional $0.82 per share, or 7.1%, to close at $10.72 per share on June 3, 2026.

OCC Denies Wise’s National Trust Bank Application

On July 24, 2026, The Wall Street Journal reported that the Office of the Comptroller of the Currency had denied Wise’s application to establish a national trust bank.

The OCC stated that the application presented significant supervisory and compliance concerns. Among other matters, the OCC identified deficiencies relating to Wise’s anti-money laundering and countering the financing of terrorism program.

According to the complaint, following this news, Wise’s U.S.-listed shares declined $0.75 per share, or 6.2%, to close at $11.33 per share on July 24, 2026.

September 29, 2026 Lead Plaintiff Deadline

Investors who purchased or otherwise acquired publicly traded Wise securities during the Class Period may, no later than September 29, 2026, seek appointment as lead plaintiff.

Investors are not required to seek appointment as lead plaintiff to remain potential members of the class. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.

Wise Investors May Have Legal Claims

Investors who acquired Wise Group securities during the Class Period and suffered financial losses are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], to discuss the class action, the lead plaintiff process or their legal rights.  

There is no cost or obligation to speak with the firm.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]